Chapel Hill, NC – The Muenzer MPS Research & Treatment Center recently traveled to San Francisco, California, where the team led a MasterClass on Mucopolysaccharidosis (MPS) at Denali Therapeutics.
Muenzer MPS Center Team members visit Denali Therapeutics
The visit highlighted the importance of collaborative partnerships in advancing research, education, and care for individuals affected by MPS. During the visit, Dr. Joseph Muenzer placed a team photo at Denali Therapeutics, symbolizing the continued partnership and shared commitment to the MPS community.
“We are deeply grateful for opportunities to collaborate with organizations like Denali Therapeutics that share our mission,” said Dr. Muenzer. “Together, we are working to improve understanding, outcomes, and hope for individuals and families living with MPS.”
The Muenzer MPS Center values collaborations that foster innovation and progress in the field of rare diseases. Through partnerships with industry, clinicians, and researchers, the Center remains dedicated to improving the lives of those impacted by MPS.
Dr. Muenzer hangs a team picture at Denali Therapeutics.
For more information about our work, visit: MPS Center